XORTX Therapeutics Inc. Proceeds From Exercise Of Warrants
XORTX Therapeutics Inc. (XRTX) reported Proceeds From Exercise Of Warrants of CAD 2.43 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-05-03.
Discontinued › Cash Flow › Financing Activities
ifrs-full:ProceedsFromExerciseOfWarrants · last filed 2022-05-03
| Period end | Proceeds From Exercise Of Warrants 12 month |
|---|---|
| 2021-12-31 | 2.43M CAD 20-F · filed 2022-05-03 |